Intelligent Bio Solutions Inc INBS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:44 PM EDT
2.37quote price arrow down-0.04 (-1.61%)
Volume
27,142
52 week range
2.16 - 44.88
Loading...
  • Open2.47
  • Day High2.47
  • Day Low2.35
  • Prev Close2.41
  • 52 Week High44.88
  • 52 Week High Date06/13/23
  • 52 Week Low2.16
  • 52 Week Low Date05/16/24

Key Stats

  • Market Cap7.391M
  • Shares Out3.12M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta4.70
  • YTD % Change-41.55

KEY STATS

  • Open2.47
  • Day High2.47
  • Day Low2.35
  • Prev Close2.41
  • 52 Week High44.88
  • 52 Week High Date06/13/23
  • 52 Week Low2.16
  • 52 Week Low Date05/16/24
  • Market Cap7.391M
  • Shares Out3.12M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta4.70
  • YTD % Change-41.55

RATIOS/PROFITABILITY

  • EPS (TTM)-64.14
  • P/E (TTM)-0.04
  • Fwd P/E (NTM)-1.06
  • EBITDA (TTM)-9.025M
  • ROE (TTM)-117.10%
  • Revenue (TTM)2.827M
  • Gross Margin (TTM)23.33%
  • Net Margin (TTM)-356.09%
  • Debt To Equity (MRQ)4.66%

EVENTS

  • Earnings Date08/27/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intelligent Bio Solutions Inc

 

Profile

MORE
Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint...
Steven Boyages Ph.D.
Chairman of the Board
Harry Simeonidis
President, Chief Executive Officer
Spiro Sakiris
Chief Financial Officer
Address
142 West 57Th St Fl11
New York, NY
10019
United States

Top Peers

SYMBOLLASTCHG%CHG
GMDAQ
Gamida Cell Ltd
0.0166+0.0004+2.4691%
ENSC
Ensysce Biosciences Inc
0.5955-0.0413-6.4856%
TTNP
Titan Pharmaceuticals Inc
6.72+0.04+0.64%
PHASQ
PhaseBio Pharmaceuticals Inc
0.00UNCHUNCH
CYCC
Cyclacel Pharmaceuticals Inc
2.09-0.03-1.48%